{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"13"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"15"}],"units":"Participants"}],"description":"Overall Response Rate in participants who tested negative for a CXCR4 mutation= Minor response (\\>25%-50% reduction in serum IgM from baseline) + Partial Response (\\>50-90% reduction in serum IgM from baseline) + Very Good Partial Response (\\>90% reduction in serum IgM from baseline) + Complete Response (resolution of all symptoms, normalization of serum IgM with disappearance of IgM paraprotein, resolution of any adenopathy or splenomegaly).","groups":[{"description":"Participants who tested negative for a CXCR4 mutation at their baseline bone marrow assessment","id":"OG000","title":"CXCR4 Wild-Type Participants"}],"paramType":"COUNT_OF_PARTICIPANTS","reportingStatus":"POSTED","timeFrame":"2 years","title":"Overall Response Rate Among Participants Without CXCR4 Mutations","type":"SECONDARY","unitOfMeasure":"Participants"}